Navigation Links
Drug Safety Firm BioSoteria Announces Exponential Growth in 2009

BioSoteria announced today that revenues grew 67% in 2009 compared to 2008. The strong growth came from an increase in new client contracts, expanded drug safety services to existing clients, and the launch of eLadder™ Safety, a comprehensive pharmacovigilance eLearning curriculum.

(PRWEB) January 28, 2010 -- BioSoteria, Inc., a privately held drug safety services and training company, announced today that revenues grew 67% in 2009 compared to 2008. The strong growth came from an increase in new client contracts, expanded services to existing clients, and the launch of eLadder™ Safety, a first-in-class comprehensive pharmacovigilance eLearning curriculum.

In 2009, BioSoteria provided consulting and safety operational services to more than 40 biotechnology and pharmaceutical companies across the US and Canada. The company’s substantial increase in revenues in 2009 was realized as clients increasingly engaged BioSoteria for strategic consulting and services in areas such as risk evaluation and mitigation strategies (REMS) and safety signal detection and analysis. Professional staff grew by 19% to support the demand for BioSoteria’s drug safety services and training offerings.

Also contributing to the increase in corporate growth was the launch of BioSoteria’s eLadder™ Safety pharmacovigilance training curriculum. The first three eLearning courses of the curriculum released in 2009 were enthusiastically received by drug safety professionals, those aspiring to enter the field of drug safety, and by biopharmaceutical companies and contract research organizations (CROs) that wish to train their safety personnel. The BioSoteria website was upgraded to include an eCommerce engine that allows individuals and small companies to purchase access to eLadder™ Safety courses online. Enterprise license options for corporate/institutional buyers were also introduced.

“I am very pleased with our leadership position in drug safety and continued growth of our company in 2009,” said Sally Van Doren, PharmD, President, CEO and Founder of BioSoteria. “In just three years, BioSoteria has grown from a small consulting firm providing services to primarily West Coast clients to a well recognized, full-service pharmacovigilance service and training provider across North America with a dedicated team of nearly 50 drug safety professionals, educational and training staff and operational support. We look forward to continuing our high quality services and extending our offerings in 2010 through business expansion and strategic partnerships.”

Highlights of 2009
-- Safety consulting and operational services were provided to more than 40 biotechnology, pharmaceutical, and over-the counter (OTC) companies, including:

  • Case intake, data entry, narratives, coding, reporting to regulatory authorities, periodic safety reporting, company core data sheet (CCDS) development and maintenance, and labeling updates
  • Patient narratives, integrated summary of safety (ISS) and other medical writing support for NDAs, BLAs, and MAAs
  • Hosted safety database solutions
  • Risk management/REMS planning, document writing, and implementation
  • Safety signal detection and analysis using client, FDA AERS, and other health databases
  • Pharmacovigilance department audits and US/EU inspection readiness
  • Product litigation consulting and support
  • Support to clients with complete response letters and programs placed on clinical hold

-- eLadder™ Safety, the first comprehensive drug safety training curriculum delivered in a true multimedia eLearning environment, was launched, with three core competency courses for drug safety professionals:

-- The BioSoteria leadership team expanded with the addition of James Buchanan, PharmD, as Senior Vice President of Pharmacovigilance and Risk Management. Dr. Buchanan has more than 20 years of industry drug safety, clinical development, and medical information services experience, and he has served as Chief Safety Officer at two past companies prior to joining BioSoteria.

-- BioSoteria moved its corporate headquarters to Emeryville CA, central to many biotechnology and pharmaceutical companies in the San Francisco Bay Area, to accommodate the current and future growth in its staff and drug safety services.

-- DSI: Drug Safety Intelligence, BioSoteria’s weekly drug safety e-newsletter, grew to nearly 1100 subscribers.

-- BioSoteria’s 3rd Annual Pacific Drug Safety Summit ( PDSS09) had the highest attendance, sponsorship and satisfaction rankings to date, making it one of the most well attended pharmacovigilance conferences in the US of the year.

-- Several of the BioSoteria senior management team accepted faculty and instructor appointments and lectured throughout the year at Universities, Schools of Pharmacy, as well as industry conferences, on drug development and drug safety.

About BioSoteria, Inc.
BioSoteria provides innovative drug safety services and educational programs to the biopharmaceutical industry. The company offers a wide range of pharmacovigilance services throughout the product lifecycle, including premarketing clinical safety surveillance, postmarketing pharmacovigilance, and risk management programs. For more information about BioSoteria, please visit the company’s website at, email, or call 1-866-660-5553.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. RFID tags to boost transit worker safety
2. FDA researchers identify new MRI safety risk for patients with pacemakers
3. Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced
4. S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders
5. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
6. BioSoteria CEO to Present at Drug Safety Conference
7. Sanofi Pasteur Presents Safety Data on Menactra(R) Vaccine Given to Infants at Infectious Disease Society Meeting
8. Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law
9. BioSoteria Drug Safety Newsletter Reaches Milestone
10. 17th International Process Development Conference to Feature Presentations on Safety, Process Development, Crystallization, PAT, Scale-Up and Production
11. Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... International ... and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. ... 2015, where ISPE hosted the largest number of attendees in more than a ...
(Date:11/24/2015)... ... , ... This fall, global software solutions leader SAP and AdVenture Capital brought ... pitch their BIG ideas to improve health and wellness in their schools. , Now, ... the title of SAP's Teen Innovator, an all-expenses paid trip to Super Bowl 50, ...
(Date:11/24/2015)... , Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced ... 29, 2015 at 11:00 a.m. Israel time, at ... 98 Yigal Allon Street, 36 th Floor, Tel Aviv, ... Eric Paneth and Izhak Tamir to the Board of ... as external directors; , approval of an amendment to certain terms ...
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading supplier of easy-to-use ... promoted Melanie Aregger to serve as Chief Operating Officer. , Having joined ... management team and was promoted to Head of InSphero Diagnostics in 2014. ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 11, 2015   Growing need ... analytical tools has been paving the way for ... determination of discrete analytes in clinical, agricultural, environmental, ... being predominantly used in medical applications, however, their ... sectors due to continuous emphasis on improving product ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
(Date:11/4/2015)... , November 4, 2015 ... new market report published by Transparency Market Research "Home Security ... Trends and Forecast 2015 - 2022", the global home security ... 30.3 bn by 2022. The market is estimated to ... period from 2015 to 2022. Rising security needs among ...
Breaking Biology News(10 mins):